Received Mar 18, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | UNK | Unknown | — |
The patient took Vivotif vaccine after eating; Case reference number US-BN-2025-001522 is a spontaneous case initially received from a consumer via Bavarian Nordic (reference number: BN_2025_00276) on 06-Sep-2025 and concerns a female patient of unspecified age. The patient's medical history and concomitant medication details were not provided. On an unspecified date, as reported, after eating the patient took Vivotif (batch number: unknown), at an unknown dose, route or site of administration for an unknown indication (explicitly coded as 'product administration error'). At the time of the initial report, it was unknown if the patient experienced any adverse events due to Vivotif. Additional information received from consumer on 09-Sep-2025 included: country of occurrence. Additional information received from consumer via Communication (reference number: USBAV25-2245) on 09-Sep-2025 included: patient gender, and additional reference number. Additional information received from Bavarian Nordic on 15-Sep-2025 included: Bavarian Nordic PQC reference: QE-018349.; Reporter's Comments: A female patient of unspecified age took Vivotif for an unknown indication after eating, which is considered as product administration error. It was unknown if the patient experienced any adverse events due to Vivotif. Product administration error is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Product administration error is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A female patient of unspecified age took Vivotif for an unknown indication after eating, which is considered as product administration error. It was unknown if the patient experienced any adverse events due to Vivotif. Product administration error is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Product administration error is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: NONE